Treatment and Prevention of Recurrent <em>Clostridium difficile</em> Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model
Toxin-induced <i>Clostridium difficile</i> infection (CDI) is a major disease characterized by severe diarrhea and high morbidity rates. The aim with this study was to develop an alternative drug for the treatment of CDI. Cows were repeatedly immunized to establish specific immunoglobuli...
Main Authors: | Hans-Jürgen Heidebrecht, William J Weiss, Mark Pulse, Anton Lange, Karina Gisch, Heike Kliem, Sacha Mann, Michael W. Pfaffl, Ulrich Kulozik, Christoph von Eichel-Streiber |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/11/2/98 |
Similar Items
-
Alteration of Intestinal Microbiome of <i>Clostridioides difficile-</i>Infected Hamsters during the Treatment with Specific Cow Antibodies
by: Hans-Jürgen Heidebrecht, et al.
Published: (2021-06-01) -
Bezlotoxumab in Patients with a Primary <i>Clostridioides difficile</i> Infection: A Literature Review
by: Guido Granata, et al.
Published: (2022-10-01) -
Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study
by: Danilo Buonsenso, et al.
Published: (2022-04-01) -
Fidaxomicin for the Treatment of <i>Clostridioides difficile</i> Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
by: Daniele Roberto Giacobbe, et al.
Published: (2022-10-01) -
A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models
by: April K. Roberts, et al.
Published: (2020-09-01)